A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days

NCT00868179 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study never started

Conditions

Thromboembolism

Interventions

DRUG: Pradax

Sponsor

Ross Leighton

Collaborators

[object Object]